The Investment Whisperer
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

The Investment Whisperer

Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin June 4, 2025
June 4, 2025
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

0
FacebookTwitterGoogle +Pinterest
previous post
5 Biggest Blockchain ETFs in 2025
next post
Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case

Related Posts

NASA Astronauts Return to Earth on SpaceX Capsule...

March 21, 2025

Radiopharm Theranostics Receives FDA IND Approval for Phase...

July 23, 2024

Westgold Strategic Alliance and Placement

May 31, 2024

Hydrogen Stocks: 9 Biggest Companies in 2024

August 31, 2024

2024 US Capital Gains Tax Guide for Gold...

December 9, 2024

FALCO ANNOUNCES CLOSING OF BROKERED PRIVATE PLACEMENT

December 21, 2024

BMR to Commence Production at Punitaqui Copper Mine...

November 10, 2023

Adrian Day: Gold Stock Investors Capitulating, Dramatic Change...

March 13, 2024

Frontier Energy

December 14, 2023

Galan Builds Inventory with 1,000t LCE, Advances HMW...

May 16, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (1,550)
    • Investing (4,201)
    • Politics (5,579)
    • World (4,762)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: TheInvestmentWhisperer.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 TheInvestmentWhisperer.com | All Rights Reserved